11:53 AM EDT, 04/01/2024 (MT Newswires) -- Autolus Therapeutics ( AUTL ) said Monday it has appointed Mike Bonney as chair, effective immediately.

Bonney succeeded John Johnson, who stepped down from the role, the company said. He previously served as chief executive of Cubist Pharmaceuticals.

Shares of the company fell more than 10% in recent trading.

Price: 5.73, Change: -0.65, Percent Change: -10.13